The FAST-Forward randomized trial from the U.K. found that ultrahypofractionated whole breast irradiation (WBI, 26 Gy in five fractions over 1 week) was just as effective as the 3-week regimen for local control. This approach ...
Feb 22, 2024
0
0
A new research perspective titled "Combining causal and correlative approaches to discover biomarkers of response to paclitaxel" has been published in Oncotarget.
Feb 21, 2024
0
0
Extremely premature infants who were fed donated breast milk had less than half the rate of a life-threatening disease than those fed formula, according to a new study led by the University of Iowa.
Feb 20, 2024
0
17
Annual breast cancer screening beginning at age 40 and continuing to at least age 79 results in the highest reduction in mortality with minimal risks, according to a new study published in Radiology.
Feb 20, 2024
0
0
In a step forward for breast cancer treatment, researchers at Tohoku University have developed a novel monoclonal antibody that specifically targets a certain type of breast cancer cell. Their findings, published in the International ...
Feb 19, 2024
0
0
Researchers at Columbia University have found a molecule that is responsible for arousing dormant cells from breast cancer and nudging them to create metastases. Silencing this molecule, called Malat1, in mice with breast ...
Feb 19, 2024
0
44
To prevent an emerging genomic technology from contributing to health disparities, a scientific team has devised new ways to improve a genetic testing method called a polygenic risk score. Since polygenic risk scores have ...
Feb 19, 2024
0
2
A study co-led by Professor Kelly Metcalfe of the Lawrence Bloomberg Faculty of Nursing, and researchers at the Familial Breast Cancer Research Unit at Women's College Hospital, finds risk-reducing mastectomies (RRM) in women ...
Feb 18, 2024
0
25
Feminist health narratives are being co-opted by commercial interests to market new technologies, tests, and treatments that are not backed by evidence, argue researchers in The BMJ today.
Feb 14, 2024
0
2
A novel three-drug combination achieved notable responses in patients with advanced HER2-negative breast cancer, according to new research directed by investigators from the Johns Hopkins Kimmel Cancer Center.
Feb 14, 2024
0
19
